Who are BeOne Medicines AG's main suppliers?

BeOne Medicines AG (ONC) key suppliers include: Amgen Inc., Amgen Inc., BRUKINSA, SONROTOCLAX, TEVIMBRA and 2 more. View the full supplier network at chainsifter.com/chain/ONC.

Who are BeOne Medicines AG's major customers?

BeOne Medicines AG (ONC) key customers include: INDEPENDENT-THIRD-PARTY, Amgen Inc., Amgen Inc., Novartis AG, Novartis AG and 4 more. View the full customer network at chainsifter.com/chain/ONC.

What sector is BeOne Medicines AG in?

BeOne Medicines AG (ONC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

BeOne Medicines AG Suppliers, Customers & Supply Chain (ONC)

7Suppliers

9Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

BeOne Medicines AG (ONC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships

2Distinct source URLs

14High confidence

0.800Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

BeOne Medicines AG Suppliers

Ticker	Name	Confidence	Evidence
AMGN	Amgen Inc.	80%	Reciprocal relationship from AMGN graph: Reciprocal relationship from ONC graph: The Company had committed capital related to the Amgen collaboration agreement
AMGN	Amgen Inc.	80%	The Company had committed capital related to the Amgen collaboration agreement
BRUKINSA	BRUKINSA	80%	we have entered into commercial supply agreements with third-party manufacturers for TEVIMBRA, BRUKINSA and sonrotoclax
SONROTOCLAX	SONROTOCLAX	80%	we have entered into commercial supply agreements with third-party manufacturers for TEVIMBRA, BRUKINSA and sonrotoclax
TEVIMBRA	TEVIMBRA	80%	we have entered into commercial supply agreements with third-party manufacturers for TEVIMBRA, BRUKINSA and sonrotoclax
NVS	Novartis AG	70%	Reciprocal relationship from NVS graph: Reciprocal relationship from ONC graph: Reciprocal relationship from NVS graph: Reciprocal relationship from ONC graph: Reciprocal relationship from NVS graph:…
NVS	Novartis AG	70%	For the three months ended March 31, 2026 and 2025, the Company’s other revenue consisted primarily of royalty revenue from IMDELLTRA ® sales outside of China under the Amgen collaboration agreement

BeOne Medicines AG Customers

Ticker	Name	Confidence	Evidence
INDEPENDENT-THIRD-PARTY	INDEPENDENT-THIRD-PARTY	92%	In 2025, the Group transferred its royalty rights to an independent third party for a fixed upfront cash consideration.
AMGN	Amgen Inc.	90%	For the three months ended March 31, 2026 and 2025, the Company’s other revenue consisted primarily of royalty revenue from IMDELLTRA ® sales outside of China under the Amgen collaboration agreement
AMGN	Amgen Inc.	90%	Reciprocal relationship from AMGN graph: Reciprocal relationship from ONC graph: Reciprocal relationship from AMGN graph: Reciprocal relationship from ONC graph: Reciprocal relationship from AMGN gra…
NVS	Novartis AG	80%	Reciprocal relationship from NVS graph: Reciprocal relationship from ONC graph: Reciprocal relationship from NVS graph: Reciprocal relationship from ONC graph: Reciprocal relationship from NVS graph:…
NVS	Novartis AG	80%	For the three months ended March 31, 2026 and 2025, the Company’s other revenue consisted primarily of royalty revenue from IMDELLTRA ® sales outside of China under the Amgen collaboration agreement
FISI	Financial Institutions, Inc.	72%	Reciprocal relationship from FISI graph: Reciprocal relationship from ONC graph: Reciprocal relationship from FISI graph: Reciprocal relationship from ONC graph: tors could materially and adversely a…
FISI	Financial Institutions, Inc.	72%	tors could materially and adversely affect our business, financial condition, results of operations, and prospects, and could reduce the value of, and any dividends payable on, our shares in foreign …
ALTHOUGH-BEONE-MEDICINES-LTD	ALTHOUGH-BEONE-MEDICINES-LTD	62%	mmercial or clinical supply of our medicines and drug candidates could be negatively impacted due to reduced operations or a shutdown of our or our third-party manufacturing facilities, distribution …
BEONE-MEDICINES-LTD	BEONE-MEDICINES-LTD	62%	mmercial or clinical supply of our medicines and drug candidates could be negatively impacted due to reduced operations or a shutdown of our or our third-party manufacturing facilities, distribution …

BeOne Medicines AG Debt Obligations

Instrument	Description	Confidence	Evidence
ONC-DEBT-11524	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-12-31.
ONC-DEBT-11523	Warrants outstanding: 184000	90%	xbrl warrant detail from xbrl 2018-12-31.
ONC-DEBT	Debt stack $1.1B	90%	Market cache reports total debt of $1.1B.

BeOne Medicines AG Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BeOne Medicines AG.

BeOne Medicines AG Ownership

Holder	Name	Confidence	Evidence
ONC-OWNER-BAKER-BROS-ADVISORS-LP	BAKER BROS. ADVISORS LP	90%	13F overlay lists BAKER BROS. ADVISORS LP as top holder; 282 tracked holders.

BeOne Medicines AG Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BSAC	Banco Santander-Chile	100.00	2
BCH	Banco de Chile	100.00	2
ARMK	Aramark	100.00	2
CHYM	Chime Financial, Inc.	100.00	2
BRBS	Blue Ridge Bankshares, Inc.	100.00	2
DTIL	Precision BioSciences, Inc.	100.00	2
ENLT	Enlight Renewable Energy Ltd	100.00	2
ARM	Arm Holdings plc	100.00	2
BLX	Banco Latinoamericano de Comercio Exterior, S. A.	100.00	2
BMA	Banco Macro S.A.	100.00	2
CNF	CNFinance Holdings Limited	100.00	2
AVAL	Grupo Aval Acciones y Valores S.A.	100.00	2
BSBR	Banco Santander (Brasil) S.A.	100.00	2
AMGN	Amgen Inc.	100.00	1	['customer', 'supplier']
BTTC	Black Titan Corporation	100.00	2
BBAR	Banco BBVA Argentina S.A.	100.00	2
VRNO	Verano Holdings Corp.	100.00	2
FNWB	First Northwest Bancorp	100.00	2
BRBI	BRBI BR Partners S.A.	100.00	2
ATLO	Ames National Corporation	100.00	2

BeOne Medicines AG Supply Chain